A detailed history of Plustick Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Plustick Management LLC holds 60,000 shares of MRNA stock, worth $1.49 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
60,000
Previous 40,000 50.0%
Holding current value
$1.49 Million
Previous $1.1 Million 40.44%
% of portfolio
0.83%
Previous 0.84%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$23.51 - $34.67 $470,200 - $693,400
20,000 Added 50.0%
60,000 $1.55 Million
Q2 2025

Aug 14, 2025

SELL
$23.65 - $28.54 $709,500 - $856,200
-30,000 Reduced 42.86%
40,000 $1.1 Million
Q1 2025

May 15, 2025

BUY
$28.35 - $47.53 $1.98 Million - $3.33 Million
70,000 New
70,000 $1.98 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Plustick Management LLC Portfolio

Follow Plustick Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plustick Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plustick Management LLC with notifications on news.